Peter G. Pappas

Active 1992–2025

143
Papers
56,566
Citations
99
h-index
141
i10-index

Citations

Citations per year for Peter G. Pappas1989: 12 citations1990: 1 citations1992: 1 citations1993: 6 citations1994: 10 citations1995: 24 citations1996: 38 citations1997: 44 citations1998: 40 citations1999: 66 citations2000: 64 citations2001: 77 citations2002: 116 citations2003: 147 citations2004: 160 citations2005: 209 citations2006: 250 citations2007: 303 citations2008: 262 citations2009: 295 citations2010: 427 citations2011: 388 citations2012: 416 citations2013: 412 citations2014: 395 citations2015: 339 citations2016: 411 citations2017: 414 citations2018: 375 citations2019: 1,452 citations2020: 1,466 citations2021: 1,423 citations2022: 964 citations2023: 813 citations2024: 1,462 citations2025: 656 citations2026: 9 citations1991: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,495 citing papers, 23.9% of this breakdownUnited Kingdom: 852 citing papers, 5.8% of this breakdownFrance: 765 citing papers, 5.2% of this breakdownChina: 754 citing papers, 5.2% of this breakdownGermany: 686 citing papers, 4.7% of this breakdownSpain: 572 citing papers, 3.9% of this breakdownBrazil: 558 citing papers, 3.8% of this breakdownItaly: 548 citing papers, 3.8% of this breakdownNetherlands: 484 citing papers, 3.3% of this breakdownAustralia: 450 citing papers, 3.1% of this breakdownCanada: 420 citing papers, 2.9% of this breakdownIndia: 406 citing papers, 2.8% of this breakdown
0%23.9%Other 31.6%

Fields

  • Medicine85.8%
  • Immunology and Microbiology4.9%
  • Biochemistry, Genetics and Molecular Biology4.7%
  • Agricultural and Biological Sciences1.3%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Health Professions0.5%
  • Other2.3%

Topics

  • Antifungal resistance and susceptibility23.7%
  • Fungal Infections and Studies18.3%
  • Nail Diseases and Treatments4.7%
  • Pneumocystis jirovecii pneumonia detection and treatment3.2%
  • Plant Pathogens and Fungal Diseases2.2%
  • Neutropenia and Cancer Infections2.1%
  • Other45.8%

Coauthors

All papers

Open in search
  1. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher C. Kibbler, Dimitrios P. Kontoyiannis, Bart Jan Kullberg, Katrien Lagrou, Frédéric Lamoth, Thomas Lehrnbecher, Jürgen Loeffler, Olivier Lortholary, Johan Maertens, Oscar Marchetti, Kieren A. Marr, Henry Masur, Jacques F. Meis, C Orla Morrisey, Márcio Nucci, Luis Ostrosky‐Zeichner, Livio Pagano, Thomas F. Patterson, John R. Perfect, Zdeněk Ráčil, Emmanuel Roilides, Marcus Ruhnke, Cornelia Schaefer Prokop, Shmuel Shoham, Monica A. Slavin, David A. Stevens, George R. Thompson, José A. Vázquez, Claudio Viscoli, Thomas J. Walsh, Adilia Warris, L. Joseph Wheat, P. Lewis White, Theoklis E. Zaoutis, Peter G. Pappas - Clinical Infectious Diseases 2019 cited by 2,817

  2. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , - Clinical Infectious Diseases 2015 cited by 4,037

  3. Invasive candidiasis

    Authors: , , , , - Nature Reviews Disease Primers 2018 cited by 1,480

  4. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theoklis E. Zaoutis, John E. Bennett - Clinical Infectious Diseases 2008 cited by 4,909

  5. Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Romanee Chaiwarith, Methee Chayakulkeeree, Sharon Chen, Yee‐Chun Chen, Yen‐Hsu Chen, Jun Yong Choi, Young Hwa Choi, Darunee Chotiprasitsakul, Jin-Won Chung, François Danion, Blandine Denis, Emilio Diaz Santos, Miguel O Dictar, Marc Diltoer, Hervé Dupont, Sizhou Feng, Maria Angeles Ferre Colomer, Ricard Ferrer, Jean-Marie Fernand Roger Forel, Jesús Fortün, Julia Garcia‐Diaz, Massimo Girardis, Fang He, Maya Hites, Mao‐Wang Ho, Patrick M. Honoré, Juan Pablo Horcajada, Haihui Huang, Po‐Yen Huang, Yong Huang, Osamah Hussein, Poj Intalapaporn, Sutep Jaruratanasirikul, Luis Jáuregui-Peredo, Misty Johnson, Dong Sik Jung, Kamonwan Jutivorakool, Winfried V. Kern, Daniel H. Kett, Thana Khawcharoenporn, Young Keun Kim, Philipp Koehler, Αναστασία Κοτανίδου, Anne M. Lachiewicz, Qinhan Lin, Luis Eduardo López Cortés, Hong Luo, Roberto Luzzati, ‪Yasmin Maor‬‏, Todd P McCarty, Maria Merelli, Paloma Merino Amador, John Midturi, Guglielmo Marco Migliorino, Jean‐Paul Mira, Piroon Mootsikapun, Orla Morrissey, Patricia Muñoz García de Paredes, Cristina Mussini, Eleftherios Mylonakis, Saadalla Nseir, William Nseir, Zekaver Odabaşı, Vasileios Papastamopoulos, David L. Paterson, Thomas F. Patterson, Kyong Ran Peck, Zhiyong Peng, Nitipong Permpalung, Gaëtan Plantefève and 42 more - The Lancet 2022 cited by 168

  6. Candidemia and Invasive Candidiasis

    Authors: , , - Infectious Disease Clinics of North America 2021 cited by 258

  7. Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 1,552

  8. Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 2,665

  9. Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 1,442

  10. Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial

    Authors: , , , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 153

  11. Clinical Efficacy and Safety of a Novel Antifungal, Fosmanogepix, in Patients with Candidemia Caused by Candida auris : Results from a Phase 2 Trial

    Authors: , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2023 cited by 78

  12. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carolyn Sasse, Rochelle Maher, Bernhardt Zeiher, Maria J. G. T. Vehreschild - The Lancet Infectious Diseases 2016 cited by 694

  13. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grégory Jouvion, David B. Meya, David S. Lawrence, Sebastian Rahn, Felix Bongomin, Brendan McMullan, Rosanne Sprute, Tinashe K. Nyazika, Justin Beardsley, Fabianne Carlesse, Christopher H. Heath, Olusola Ayanlowo, Olga Mashedi, Flávio Queiróz-Telles Filho, Mina C. Hosseinipour, Atul Patel, Elvis Temfack, Nina Singh, Oliver A. Cornely, David R. Boulware, Olivier Lortholary, Peter G. Pappas, John R. Perfect - The Lancet Infectious Diseases 2024 cited by 269

  14. Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials

    Authors: , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2023 cited by 73

  15. Combination Antifungal Therapy for Invasive Aspergillosis

    Authors: , , , , , , , , , , , , , , , , , , - Annals of Internal Medicine 2015 cited by 500

  16. Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial

    Authors: , , , , , , , , , , , , , , , , - Journal of Antimicrobial Chemotherapy 2023 cited by 59

  17. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacques F. Meis, M. Hong Nguyen, Zoi Dorothea Pana, Peter‐Michael Rath, Ilana Reinhold, Danila Seidel, Takahiro Takazono, Donald C. Vinh, Sean X. Zhang, Javier Afeltra, Abdullah M. S. Al‐Hatmi, Amir Arastehfar, Sevtap Arıkan-Akdağlı, Felix Bongomin, Fabianne Carlesse, Methee Chayakulkeeree, Louis Yi Ann Chai, Leili Chamani‐Tabriz, Tom Chiller, Anuradha Chowdhary, Cornelius J. Clancy, Arnaldo Lopes Colombo, Andrea Cortegiani, Dora Corzo-León, Ľuboš Drgoňa, Anna Dudakova, Joveria Farooqi, Sara Gago, Macit İlkit, Jeffrey D. Jenks, Н Н Климко, Robert Krause, Anil Kumar, Katrien Lagrou, Michail S. Lionakis, B. Lmimouni, Michael K. Mansour, Joseph Meletiadis, Sibylle C. Mellinghoff, Mervyn Mer, Małgorzata Mikulska, Philippe Montravers, Chin Fen Neoh, Volkan Özenci, Livio Pagano, Peter G. Pappas, Thomas F. Patterson, Pedro Puerta‐Alcalde, Laman Rahimli, Sebastian Rahn, Emmanuel Roilides, Coleman Rotstein, Tamara Ruegamer, Raquel Sabino, Jon Salmanton‐García, Ilan S. Schwartz, Esther Segal, Neeraj Sidharthan, Tanu Singhal, János Sinkó, Rajeev Soman, Andrej Spec, Joerg Steinmann, Jannik Stemler, Saad J. Taj‐Aldeen, Alida Fe Talento, George R Thompson, Christina Toebben, Hiram Villanueva‐Lozano, Retno Wahyuningsih and 5 more - The Lancet Infectious Diseases 2025 cited by 296

  18. Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2008 cited by 460

  19. Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , - Clinical Infectious Diseases 2016 cited by 1,283

  20. A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristie Johnson, Julianne V. Kus, Ruoyu Li, Jacques F. Meis, Michaela Lackner, Fanny Lanternier, Sixto M. Leal, Francesca Lee, Shawn R. Lockhart, Paul M. Luethy, Isabella W. Martin, Kyung J. Kwon‐Chung, Wieland Meyer, M. Hong Nguyen, Luis Ostrosky‐Zeichner, Elizabeth Palavecino, Preeti Pancholi, Peter G. Pappas, Gary W. Procop, Scott A. Redhead, Daniel D. Rhoads, Stefan Riedel, Bryan S. Stevens, Kaede Ota Sullivan, Paschalis Vergidis, Emmanuel Roilides, Amir Seyedmousavi, Lili Tao, Vânia Aparecida Vicente, Roxana G. Vitale, Qiming Wang, Nancy L. Wengenack, Lars F. Westblade, Nathan P. Wiederhold, Lewis White, Christina Wojewoda, Sean X. Zhang - Journal of Clinical Microbiology 2023 cited by 61

  21. Recommendations on prevention of infections during chimeric antigen receptor T‐cell and bispecific antibody therapy in multiple myeloma

    Authors: , , , , , , , , , - British Journal of Haematology 2023 cited by 73

  22. Invasive Non- Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Emerging infectious diseases 2011 cited by 319

  23. Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2009 cited by 3,207

  24. MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nikolaos G. Almyroudis, David R. Andes, Susan Hadley, Michelle Barron, Katheen Mullane, Loren G. Miller - Journal of Antimicrobial Chemotherapy 2019 cited by 86